diclofenac 75 mg
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration and Perforation ). Diclofenac sodium delayed-release tablets are indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Rising Pharmaceuticals, Inc.
ROUND BROWN P 75
P 75 ROUND BROWN
Related Pills
diclofenac 50 mg
Rising Pharma Holdings, Inc.
diclofenac 25 mg
rising pharma holdings, inc.
diclofenac 75 mg
rising pharmaceuticals, inc.
diclofenac sodium tablet delayed release
Pack Pharmaceuticals, LLC
diclofenac sodium 75 mg
American Health Packaging
diclofenac 75 mg
pack pharmaceuticals, llc
diclofenac sodium tablet delayed release
Pack Pharmaceuticals, LLC
diclofenac sodium tablet delayed release
Pack Pharmaceuticals, LLC
diclofenac sodium tablet delayed release
pack pharmaceuticals, llc
diclofenac sodium tablet delayed release
pack pharmaceuticals, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
DICLOFENAC SODIUM delayed-release tablets, USP, for oral administration, are available as: 25 mg: round, light brown, enteric-coated tablets P 25 imprinted on one side in black ink and plain on the reverse side are supplied as: Bottles of 30........................................ NDC 16571-203-03 Bottles of 100.......................................NDC 16571-203-10 50 mg: round, light brown, enteric-coated tablets P 50 imprinted on one side in black ink and plain on the reverse side are supplied as: Bottles of 60.........................................NDC 16571-202-06 Bottles of 100.......................................NDC 16571-202-10 Bottles of 1000.....................................NDC 16571-202-11 75 mg: round, light brown, enteric-coated tablets P 75 imprinted on one side in black ink and plain on the reverse side are supplied as: Bottles of 60.........................................NDC 16571-201-06 Bottles of 100.......................................NDC 16571-201-10 Bottles of 500.......................................NDC 16571-201-50 Bottles of 1000.....................................NDC 16571-201-11 Store at 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature). Protect from moisture. Dispense in a tight, light-resistant container. Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 1-800-521-5340 139661 Jul. 2024 logo
More pills like ROUND P 75